New 4-Hour blood test could predict cancer treatment success
NCT ID NCT07155811
Summary
This study is testing a new automated blood test that measures immune cell activity to see if it can predict how well standard immunotherapy works for patients with advanced solid tumors. Researchers will enroll 100 adults about to start immunotherapy to see if the test results correlate with how their cancer responds to treatment. The goal is to gather information that could one day help doctors better personalize cancer care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.